Pfizer sees upbeat 2018 on lower tax rate, shares dip after highs

(Reuters) - Pfizer Inc forecast 2018 profit and revenue well ahead of analysts' estimates on Tuesday as it expects to benefit from reduced tax rate following the recent changes to the U.S. tax code, and recorded an $11 billion gain from the overhaul.

Pfizer sees upbeat 2018 on lower tax rate, shares dip after highs
Read More


Bagikan Berita Ini